Practical Barriers and Facilitators Experienced by Patients, Pharmacists and Physicians to the Implementation of Pharmacogenomic Screening in Dutch Outpatient Hospital Care-An Explorative Pilot Study.
implementation
personalized medicine
pharmacogenetics
pharmacogenomics
pre-emptive
precision medicine
screening
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
21 Dec 2020
21 Dec 2020
Historique:
received:
18
11
2020
revised:
11
12
2020
accepted:
18
12
2020
entrez:
29
12
2020
pubmed:
30
12
2020
medline:
30
12
2020
Statut:
epublish
Résumé
Pharmacogenomics (PGx) can provide optimized treatment to individual patients while potentially reducing healthcare costs. However, widespread implementation remains absent. We performed a pilot study of PGx screening in Dutch outpatient hospital care to identify the barriers and facilitators to implementation experienced by patients (
Identifiants
pubmed: 33371313
pii: jpm10040293
doi: 10.3390/jpm10040293
pmc: PMC7767378
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : University Medical Center Groningen
ID : CDO15.0022
Organisme : Netherlands Organization for Scientific Research
ID : SPI 92-266
Références
Clin Pharmacol Ther. 2012 Mar;91(3):450-8
pubmed: 22278335
Clin Pharmacol Ther. 2011 May;89(5):662-73
pubmed: 21412232
Lancet. 2013 Jun 1;381(9881):1903
pubmed: 23725729
Clin Pharmacol Ther. 2008 May;83(5):781-7
pubmed: 18253145
J Clin Med. 2020 Mar 17;9(3):
pubmed: 32192029
Public Health Genomics. 2014;17(5-6):287-98
pubmed: 25401385
Clin Pharmacol Ther. 2013 Aug;94(2):207-10
pubmed: 23588301
BMC Med. 2019 Jun 14;17(1):110
pubmed: 31196067
Annu Rev Pharmacol Toxicol. 2015;55:89-106
pubmed: 25292429
Ned Tijdschr Geneeskd. 2020 Jun 4;164:
pubmed: 32608920
Front Genet. 2020 Jan 31;11:10
pubmed: 32076434
Clin Pharmacol Ther. 2014 Apr;95(4):423-31
pubmed: 24253661
Hum Genomics. 2019 Aug 27;13(1):39
pubmed: 31455423